Is Stat3 and/or p53 mRNA expression a prognostic marker for renal cell carcinoma?

Biomedical Research

Volumn 30, Issue 3, 2009, Pages 171-176

  Masuda, Akinori ^a   Kamai, Takao ^a   Abe, Hideyuki ^a   Arai, Kyoko ^a   Yoshida, Ken Ichiro ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN P53; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; OVERALL SURVIVAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; GENETICS; JAPAN; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; GENES, P53; HUMANS; JAPAN; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70149091360     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.30.171     Document Type: Article

References (18)

1. Arredondo J, Chernyavsky, AI, Marubio LM, Beaudet AL, Jolkovsky DL, Pinkerton KE and Grando SA (2005) Receptor-Mediated Tobacco Toxicity. Regulation of gene expression through α3β2 nicotinic receptor in oral epithelial cells. Am J Pathol 166, 597-613.
2. Buettner R, Mora LB, and Jove R (2002) Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8, 945-954.
3. Cohen HT and McGovern FJ (2005) Renal-cell carcinoma. N Engl J Med 353, 2477-2490.
4. Horiguchi A, Oya M, Shimada T, Uchida A, Marumo K and Murai M (2002) Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome. J Urol 168, 762-765.
5. Ito N, Eto M, Nakamura E, Takahashi A, Tsukamoto T, Toma H, Nakazawa H, Hirao Y, Uemura H, Kagawa S, Kaneyama H, Nose Y, Kinukawa N, Nakamura T, Jinnai N, Seki T, Takamatsu M, Masui Y, Naito S and Ogawa O (2007) STAT3 polymorphism predicts interferon-alpha response in patients with metastatic renal cell carcinoma. J Clin Oncol 25, 2785-2791.
6. Kamai T, Arai K, Tsujii T, Honda M and Yoshida K-I (2001) Overexpression of RhoA mRNA is associated with advanced stage in testicular germ cell tumor. BJU Int 87, 227-231.
7. Kamai T, Tsujii T, Arai K, Takagi K, Asami H, Ito Y, Oshima H and Yoshida K-I (2003) Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 9, 2632-2641.
8. Kamai T, Yanai Y, Arai K, Abe H, Yamanishi T, Kurimoto M and Yoshida K-I (2007) Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasis. BMC Cancer 7, 1471-2407-7-159.
9. Lin J, Tang H, Jin X, Jia G and Hsieh JT (2002) p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3. Oncogene 21, 3082-3088.
10. Lin JX, Jin K, Rothman K, Lin HJ, Tang H and Burke W (2002) Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cell. Cancer Res 62, 376-380.
11. Motzer RJ, Bander NH and Nanus DM (1996) Renal-cell carcinoma. N Engl J Med 335, 865-875.
12. Niu G, Wright KL, Ma Y, Wright GM, Huang M, Irby R, Briggs J, Karras J, Cress WD, Pardoll D, Jove R, Chen J and Yu H (2005) Role of Stat3 in regulating p53 expression and function. Mol Cell Biol 25, 7432-7440.
13. Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, Marks J and Sukumar S (2000) Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 405, 974-978.
14. Sobin LH and Wittekind CH, eds. (2002) International union against cancer. UICC, In: TNM Classification of Malignant Tumors, 6th ed., Wiley-Liss, New York.
15. Suwa H, Ohshio G. Imamura T, Watanabe G, Arii S, Imamura M, Narumiya S, Hiai H and Fukumoto M (1998) Over-expression of the rho C gene correlates with progression of ductal adenocarcinoma of the pancreas. Br J Cancer 77, 147-152.
16. Takaoka A, Hayakawa S, Yanai H, Stoiber D, Negishi H, Kikuchi H, Sasaki S, Imai K, Shibue T, Honda K and Taniguchi T (2003) Integration of interferon-alpha/beta signaling to p53 responses in tumour suppression and antiviral defence. Nature 424, 516-523.
17. Vogelstein B, Lano D and Levine AJ (2000) Surfing the p53 network. Nature 408, 307-310.
18. Yu H and Jove R (2004) The STATs of cancer - New molecular targets come of age. Nat Rev Cancer 4, 97-105.